Patent: 10,357,559
✉ Email this page to a colleague
Summary for Patent: 10,357,559
| Title: | Temperature stable vaccine formulations |
| Abstract: | Vaccine antigen formulations that are stable after undergoing freeze and thaw conditions and methods of preparing the formulations are provided. Methods of using the formulations to prepare vaccine are also provided. Vaccines comprising the formulations are useful, for example, to protect against, inhibit or alleviate a disease or infection, such as related to anthrax infection. |
| Inventor(s): | Jee Look, Christian Fernando Ruiz, Aaron Paul Miles, Richard William Welch |
| Assignee: | Emergent Product Development Gaithersburg Inc |
| Application Number: | US15/108,244 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 10,357,559
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emergent Product Development Gaithersburg, Inc. | CYFENDUS | anthrax vaccine adsorbed, adjuvanted | Injection | 125761 | July 20, 2023 | 10,357,559 | 2034-12-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,357,559
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015100344 | ⤷ Start Trial |
| United States of America | 2016324957 | ⤷ Start Trial |
| European Patent Office | 3086780 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
